Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Diabetes
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending T
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Diabetes
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Wave Life Sciences
Biotech
Wave surfs DMD success to regulators' doors, sending stock up
Wave has met its goal in a Duchenne muscular dystrophy study, positioning it to talk to regulators about accelerated approval.
Nick Paul Taylor
Sep 24, 2024 9:51am
Sanofi, Pfizer, Acelyrin and more—Chutes & Ladders
May 10, 2024 8:30am
Wave's ALS-dementia drug crashes out after early-phase flop
May 23, 2023 9:30am
GSK stands by dumping cell therapies as oligo strategy heats up
Feb 17, 2023 6:30am
Avidity pushes new phase 1/2 data as FDA hold remains in place
Dec 14, 2022 11:00am
GSK pays $170M upfront to continue to ride oligonucleotide wave
Dec 13, 2022 10:24am